MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,464,000 | -24.7% | 9,829,354 | -2.1% | 0.03% | -27.7% |
| Q2 2022 | $11,240,000 | -12.7% | 10,035,970 | -12.7% | 0.05% | -7.8% |
| Q1 2022 | $12,874,000 | -24.2% | 11,495,000 | +8.3% | 0.05% | -25.0% |
| Q4 2021 | $16,976,000 | -29.7% | 10,610,000 | +6.4% | 0.07% | -35.8% |
| Q3 2021 | $24,140,000 | -24.7% | 9,975,000 | -1.3% | 0.11% | -26.4% |
| Q2 2021 | $32,040,000 | +14.9% | 10,107,189 | +22.1% | 0.14% | +10.8% |
| Q1 2021 | $27,892,000 | +3643.9% | 8,276,500 | +2809.5% | 0.13% | +3150.0% |
| Q3 2020 | $745,000 | -35.1% | 284,469 | -24.1% | 0.00% | -42.9% |
| Q2 2020 | $1,148,000 | – | 375,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |